AILERON THERAPEUTICS INC — Form D

AILERON THERAPEUTICS INC of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2014-10-29. The offering totals $33.0M, of which $19.8M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Enrico H PetrilloDirectorCambridge, MA
Seth HarrisonDirectorRedwood City, CA
Alan H MussoDirectorWaltham, MA
Reinhard J AmbrosDirectorWaltham, MA
Nolan H Sigal, M.D., Ph.D.DirectorWaltham, MA
William H FaireyDirectorWaltham, MA
Josef H von RickenbachDirectorWaltham, MA
Manuel Alves-Aivado, M.D., Ph.D.DirectorWaltham, MA
Manuel Alves-Aivado, M.D., Ph.D.Executive OfficerWaltham, MA
Brian L Windsor, Ph.D.Executive OfficerWaltham, MA
Susan L DrexlerExecutive OfficerWaltham, MA
Campbell MurrayDirectorNOVATO, CA
Enrico PetrilloDirectorBoston, MA
Manuel H AivadoExecutive OfficerCambridge, MA
Caleb H WinderDirectorCambridge, MA
John H McArthurDirectorCambridge, MA
Joseph A Yanchik IIIDirectorCambridge, MA
Joseph A Yanchik IIIExecutive OfficerCambridge, MA
Brian M Gallagher, Jr.DirectorCambridge, MA
Armen H ShanafeltDirectorCambridge, MA
Scott L KapnickDirectorCambridge, MA
Michael DiemDirectorConshocken, PA
Seth L HarrisonDirector

Other filings by this issuer (4)

FiledFormOfferingSold
2023-11-16D$18.3M$18.3M
2017-01-06D$40.0M$30.1M
2013-11-19D$30.0M$15.0M
2009-06-12D$40.1M$28.1M

More